Eventide Asset Management, LLC 13D and 13G filings for Aura Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-14 3:28 pm Unchanged |
2025-03-31 | 13G | Aura Biosciences, Inc. AURA |
Eventide Asset Management, LLC | 0 0.000% |
0 (Unchanged) |
Filing |
| 2025-05-13 5:28 pm Sale |
2025-03-31 | 13G | Aura Biosciences, Inc. AURA |
Eventide Asset Management, LLC | 0 0.000% |
-4,080,605 (Position Closed) |
Filing |
| 2025-02-14 11:56 am Sale |
2024-12-31 | 13G | Aura Biosciences, Inc. AURA |
Eventide Asset Management, LLC | 4,080,605 8.170% |
-1,722,077 (-29.68%) |
Filing |
| 2023-12-11 5:14 pm Purchase |
2023-11-30 | 13G | Aura Biosciences, Inc. AURA |
Eventide Asset Management, LLC | 5,802,682 11.820% |
3,551,314 (+157.74%) |
Filing |
| 2023-02-14 1:30 pm Purchase |
2022-12-31 | 13G | Aura Biosciences, Inc. AURA |
Eventide Asset Management, LLC | 2,251,368 6.300% |
2,251,368 (New Position) |
Filing |